Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks

被引:19
作者
Saez-Cirion, Asier
Versmisse, Pierre
Truong, Lien X.
Chakrabarti, Lisa A.
Carpentier, Wassila
Barre-Sinoussi, Francoise
Scott-Algara, Daniel
Pancino, Gianfranco
机构
[1] Inst Pasteur, Unite Regulat Infect Retrovirales, F-75015 Paris, France
[2] Inst Pasteur, Retrovirol & Viral Hepatitis Lab, Ho Chi Minh City, Vietnam
[3] Inst Pasteur, Lab Pathogenie Virale Mol, F-75015 Paris, France
[4] Univ Paris 06, UR INSERM 543, Lab Immunol Cellulaire, Paris, France
[5] Inst Pasteur, Unite Immunogenet Cellulaire, F-75015 Paris, France
关键词
D O I
10.1186/1742-4690-3-81
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: We have previously reported that CD4 T cells from some exposed uninfected (EU) Vietnamese intravenous drug users are relatively resistant to HIV infection in vitro. Here, we further characterized the restriction of viral replication in CD4 T cells from five EUs and assessed its persistence in serial samples. Results: CD4 T cells and/or PBMC sampled during a period of between 2 and 6 years were challenged with replication-competent HIV-1 and other retroviral particles pseudotyped with envelope proteins of various tropisms. CCR5 expression and function in resistant CD4 T cells was evaluated. The step at which HIV-1 replication is restricted was investigated by real-time PCR quantification of HIV-1 reverse transcripts. We identified three patterns of durable HIV-1 restriction in EU CD4 T cells. CD4 T cells from four of the five EU subjects were resistant to HIV-1 R5 infection. In two cases this resistance was associated with low CCR5 surface expression, which was itself associated with heterozygous CCR5 mutations. In the other two cases, CD4 T cells were resistant to HIV-1 R5 infection despite normal CCR5 expression and signaling function, and normal beta-chemokine secretion upon CD4 T cell activation. Instead, restriction appeared to be due to enhanced CD4 T cell sensitivity to beta-chemokines in these two subjects. In the fifth EU subject the restriction involved post-entry steps of viral replication and affected not only HIV-1 but also other lentiviruses. The restriction was not overcome by a high viral inoculum, suggesting that it was not mediated by a saturable inhibitory factor. Conclusion: Various constitutive mechanisms of CD4 T cell resistance to HIV-1 infection, affecting entry or post-entry steps of viral replication, are associated with resistance to HIV-1 in subjects who remain uninfected despite long-term high-risk behavior.
引用
收藏
页数:12
相关论文
共 57 条
[2]   A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[3]   CXCR4-Tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes [J].
Balabanian, K ;
Harriague, J ;
Décrion, C ;
Lagane, B ;
Shorte, S ;
Baleux, F ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Chakrabarti, LA .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7150-7160
[4]   Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32 [J].
Benkirane, M ;
Jin, DY ;
Chun, RF ;
Koup, RA ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30603-30606
[5]   Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity [J].
Blanpain, C ;
Lee, B ;
Vakili, J ;
Doranz, BJ ;
Govaerts, C ;
Migeotte, I ;
Sharron, M ;
Dupriez, V ;
Vassart, G ;
Doms, RW ;
Parmentier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :18902-18908
[6]   Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1 [J].
Butera, ST ;
Pisell, TL ;
Limpakarnjanarat, K ;
Young, NL ;
Hodge, TW ;
Mastro, TD ;
Folks, TM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (08) :735-744
[7]   New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia [J].
Capoulade-Métay, C ;
Ma, LY ;
Truong, LX ;
Dudoit, Y ;
Versmisse, P ;
Nguyen, NV ;
Nguyen, M ;
Scott-Algara, D ;
Barré-Sinoussi, F ;
Debré, P ;
Bismuth, G ;
Pancino, G ;
Theodorou, I .
AIDS, 2004, 18 (17) :2243-2252
[8]   Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells [J].
Chanel, C ;
Staropoli, I ;
Baleux, F ;
Amara, A ;
Valenzuela-Fernandez, A ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Altmeyer, R .
AIDS, 2002, 16 (17) :2337-2340
[9]   Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor [J].
Chelli, M ;
Alizon, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :46975-46982
[10]   RETRACTED: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010) [J].
Chiu, YL ;
Soros, VB ;
Kreisberg, JF ;
Stopak, K ;
Yonemoto, W ;
Greene, WC .
NATURE, 2005, 435 (7038) :108-114